These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 17213254

  • 1. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
    Boonen A, van der Heijde D, Landewé R, van Tubergen A, Mielants H, Dougados M, van der Linden S.
    Ann Rheum Dis; 2007 Jun; 66(6):771-7. PubMed ID: 17213254
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [Abstract] [Full Text] [Related]

  • 3. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M.
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [Abstract] [Full Text] [Related]

  • 4. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W.
    Clin Exp Rheumatol; 2011 Jun; 29(4):661-71. PubMed ID: 21813061
    [Abstract] [Full Text] [Related]

  • 5. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S, Hockley C.
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the validity of two indirect utility instruments as measures of postoperative recovery.
    Lee L, Mata J, Augustin BR, Carli F, Morin N, Latimer E, Feldman LS.
    J Surg Res; 2014 Jul; 190(1):79-86. PubMed ID: 24629417
    [Abstract] [Full Text] [Related]

  • 7. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
    Boonen A, Patel V, Traina S, Chiou CF, Maetzel A, Tsuji W.
    J Rheumatol; 2008 Apr; 35(4):662-7. PubMed ID: 18278836
    [Abstract] [Full Text] [Related]

  • 8. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
    Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM.
    Value Health; 2011 Apr; 14(5):732-9. PubMed ID: 21839412
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, Fong KY, Thumboo J.
    Arthritis Rheum; 2007 Aug 15; 57(6):1043-9. PubMed ID: 17665466
    [Abstract] [Full Text] [Related]

  • 10. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL, Yue M, Yang H, Wang T, Wu JH, Li SC.
    Value Health; 2010 Aug 15; 13(5):649-56. PubMed ID: 20412540
    [Abstract] [Full Text] [Related]

  • 11. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P, Patel A, Knapp M, Schene A, Koeter M, Amaddeo F, Ruggeri M, Giessler A, Puschner B, Thornicroft G.
    J Ment Health Policy Econ; 2009 Mar 15; 12(1):27-31. PubMed ID: 19346564
    [Abstract] [Full Text] [Related]

  • 12. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
    Kanters TA, Redekop WK, Kruijshaar ME, van der Ploeg AT, Rutten-van Mölken MP, Hakkaart L.
    Qual Life Res; 2015 Apr 15; 24(4):837-44. PubMed ID: 25342117
    [Abstract] [Full Text] [Related]

  • 13. EQ-5D versus SF-12 in coronary patients: are they interchangeable?
    De Smedt D, Clays E, Annemans L, De Bacquer D.
    Value Health; 2014 Apr 15; 17(1):84-9. PubMed ID: 24438721
    [Abstract] [Full Text] [Related]

  • 14. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.
    Ann Rheum Dis; 2012 Sep 15; 71(9):1478-83. PubMed ID: 22419775
    [Abstract] [Full Text] [Related]

  • 15. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA.
    Arthritis Care Res (Hoboken); 2012 Jun 15; 64(6):826-32. PubMed ID: 22262513
    [Abstract] [Full Text] [Related]

  • 16. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
    Lillegraven S, Kristiansen IS, Kvien TK.
    Ann Rheum Dis; 2010 Oct 15; 69(10):1762-7. PubMed ID: 20448285
    [Abstract] [Full Text] [Related]

  • 17. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C, Ferrara P, Gerónimo-Pardo M.
    Eur J Health Econ; 2020 Jun 15; 21(4):649-662. PubMed ID: 32065301
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
    Kwakkenbos L, Fransen J, Vonk MC, Becker ES, Jeurissen M, van den Hoogen FH, van den Ende CH.
    Clin Exp Rheumatol; 2013 Jun 15; 31(2 Suppl 76):50-6. PubMed ID: 23910610
    [Abstract] [Full Text] [Related]

  • 19. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N, Boonen A, van den Bergh JP, van Kuijk SMJ, Wyers CE, van Oostwaard M, Vranken L, Bours SPG, Hiligsmann M.
    J Med Econ; 2022 Jun 15; 25(1):829-839. PubMed ID: 35674412
    [Abstract] [Full Text] [Related]

  • 20. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS, Honeycutt AA, Neuwahl SJ, Barber MD, Richter HE, Visco AG, Sung VW, Shepherd JP, Rogers RG, Jakus-Waldman S, Mazloomdoost D, NICHD Pelvic Floor Disorders Network.
    Am J Obstet Gynecol; 2019 Mar 15; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.